CY1122803T1 - Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων - Google Patents

Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων

Info

Publication number
CY1122803T1
CY1122803T1 CY20201100157T CY201100157T CY1122803T1 CY 1122803 T1 CY1122803 T1 CY 1122803T1 CY 20201100157 T CY20201100157 T CY 20201100157T CY 201100157 T CY201100157 T CY 201100157T CY 1122803 T1 CY1122803 T1 CY 1122803T1
Authority
CY
Cyprus
Prior art keywords
production line
seed production
line processes
processes
seed
Prior art date
Application number
CY20201100157T
Other languages
English (en)
Inventor
Michael Bruninghaus
Konstantin Konstantinov
Benjamin Wright
Weichang Zhou
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53477008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1122803(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of CY1122803T1 publication Critical patent/CY1122803T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/28—Constructional details, e.g. recesses, hinges disposable or single use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/58—Reaction vessels connected in series or in parallel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16—Vibrating; Shaking; Tilting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Abstract

Στο παρόν έγγραφο παρέχονται διαδικασίες και μέθοδοι γραμμής παραγωγής σπόρων για την παραγωγή ανασυνδυασμένης πρωτεΐνης που περιλαμβάνουν τη χρήση αυτών των διαδικασιών γραμμής παραγωγής σπόρων.
CY20201100157T 2014-06-09 2020-02-19 Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων CY1122803T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462009553P 2014-06-09 2014-06-09
PCT/US2015/034709 WO2015191462A1 (en) 2014-06-09 2015-06-08 Seed train processes and uses thereof

Publications (1)

Publication Number Publication Date
CY1122803T1 true CY1122803T1 (el) 2021-05-05

Family

ID=53477008

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100157T CY1122803T1 (el) 2014-06-09 2020-02-19 Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων

Country Status (18)

Country Link
US (2) US10570367B2 (el)
EP (3) EP3628730A1 (el)
JP (3) JP6784600B2 (el)
KR (2) KR102584375B1 (el)
CN (2) CN106574249B (el)
AU (3) AU2015274897B2 (el)
BR (1) BR112016028891B1 (el)
CA (1) CA2951551C (el)
CY (1) CY1122803T1 (el)
DK (1) DK3152299T3 (el)
ES (1) ES2773630T3 (el)
HU (1) HUE047683T2 (el)
IL (3) IL290096B2 (el)
MX (2) MX2016016301A (el)
RU (1) RU2694327C2 (el)
SG (1) SG11201610216UA (el)
TW (3) TWI707949B (el)
WO (1) WO2015191462A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3460049A1 (en) 2013-02-22 2019-03-27 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
SG11201506343QA (en) 2013-02-22 2015-09-29 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
BR112017013423B1 (pt) 2014-12-22 2023-04-11 Genzyme Corporation Métodos para cultivo de célula de mamífero
EP3368176A2 (en) * 2015-10-26 2018-09-05 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
WO2018116967A1 (ja) * 2016-12-22 2018-06-28 東亞合成株式会社 接着剤組成物並びにこれを用いたカバーレイフィルム、ボンディングシート、銅張積層板及び電磁波シールド材
WO2019055796A1 (en) * 2017-09-15 2019-03-21 Bristol-Myers Squibb Company ONLINE BIOMASS CAPACITY MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST
TW202003832A (zh) * 2018-05-04 2020-01-16 美商健臻公司 具有過濾系統的灌注式生物反應器
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
EP3650528A1 (en) * 2018-11-08 2020-05-13 Aglaris Ltd Cell culture system and method
KR20210120015A (ko) * 2019-01-25 2021-10-06 엔진 바이오사이언스 리미티드 치료 단백질 생산을 위한 자동화 통합 연속 시스템 및 바이오 공정
US20220119757A1 (en) * 2019-02-15 2022-04-21 Just-Evotec Biologics, Inc. Automated biomanufacturing systems, facilities, and processes
WO2020243006A1 (en) * 2019-05-24 2020-12-03 Rubius Therapeutics, Inc. Methods of generating enucleated erythroid cells
GB201908612D0 (en) * 2019-06-17 2019-07-31 Ge Healthcare Bio Sciences Ab A method for separating biomolecules
JP2022540920A (ja) * 2019-07-16 2022-09-20 イノベント バイオロジクス（スーチョウ）カンパニー，リミティド 高密度連続接種の細胞培養方法及びその応用
EP3831924A1 (en) * 2019-12-03 2021-06-09 Sartorius Stedim Data Analytics AB Adapting control of a cell culture in a production scale vessel with regard to a starting medium
WO2024006236A1 (en) * 2022-06-28 2024-01-04 Amgen Inc. Flexible facility configurations for therapeutic product manufacturing
US20240076604A1 (en) * 2022-09-06 2024-03-07 Amgen Inc. Large scale bioreactor system and method

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2058992C1 (ru) 1993-07-14 1996-04-27 Антипин Георгий Васильевич Способ получения кормового белка и устройство для его осуществления
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
RU2215748C2 (ru) 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
JP4176472B2 (ja) * 2000-12-20 2008-11-05 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞の種連続増殖（ｓｅｅｄ−ｔｒａｉｎｅｘｐａｎｓｉｏｎ）のための装置及び方法
JP2005509406A (ja) 2001-05-09 2005-04-14 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞株のための低温保存袋アセンブリー
DE60238863D1 (de) 2001-08-31 2011-02-17 Bayer Schering Pharma Ag Vorrichtung und verfahren zur fermentation in hohen zelldichten
CA2460206C (en) 2001-10-02 2012-01-24 Novo Nordisk Health Care Ag Method for production of recombinant proteins in eukaryote cells
AU2002348151A1 (en) 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US20050019914A1 (en) * 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
FR2866655B1 (fr) 2004-02-20 2007-05-11 Cesco Bioengineering Co Ltd Appareil et procede pour la preparation et la mise en culture de cellules
US7294484B2 (en) * 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
JP4914835B2 (ja) 2004-09-16 2012-04-11 ベクトン・ディキンソン・アンド・カンパニー 細胞培養用の潅流バイオリアクタ
LT2550971T (lt) 2004-09-30 2018-10-25 Bayer Healthcare Llc Biologinių molekulių integruotos nepertraukiamos gamybos aparatai ir būdai
WO2006138143A1 (en) 2005-06-15 2006-12-28 Amprotein Corporation Suspension culture vessels
ES2662589T3 (es) 2005-06-15 2018-04-09 Zhejiang Jinyishengshi Bioengineering Co., Ltd. Recipientes para cultivo en suspensión
WO2008024769A2 (en) 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
US20080207487A1 (en) 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
US8501462B2 (en) 2007-02-27 2013-08-06 The Board Of Trustees Of The University Of Illinois Insert device for multiwell plate
MX2009009156A (es) * 2007-03-02 2009-09-04 Boehringer Ingelheim Pharma Mejora de la produccion de proteina.
AU2007351639B2 (en) 2007-04-17 2012-12-13 Propharma Group Europe B.V. Method and device for continuous membrane adsorption
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
WO2009023562A2 (en) 2007-08-09 2009-02-19 Wyeth Use of perfusion to enhance production of fed-batch cell culture in bioreactors
WO2009034186A2 (en) 2007-09-13 2009-03-19 Helmholtz-Zentrum für Infektionsforschung GmbH Process for cell cultivation
US20090233334A1 (en) 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
DE102008019691A1 (de) 2008-04-15 2009-10-29 Technische Universität Ilmenau Teilaktives mikrofluidisches System für die 3D-Zellkultivierung sowie Verfahren zu dessen Perfusion
CN101821378B (zh) 2008-06-16 2015-07-08 浙江金仪盛世生物工程有限公司 生物反应器
WO2010120514A2 (en) 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
CN102482633A (zh) * 2009-07-06 2012-05-30 弗·哈夫曼-拉罗切有限公司 真核细胞的培养方法
CN105107228B (zh) * 2010-12-06 2017-03-29 颇尔公司 生物制品的连续加工方法
SI2665806T1 (sl) 2011-01-17 2021-11-30 F. Hoffmann-La Roche Ag Aparat za separacijo
EP2707488B1 (en) 2011-05-12 2017-11-15 ProBioGen AG Enhancement of protein production yield mediated by a fast shuttling cdc42 gtpase
SG10201702537RA (en) 2011-07-01 2017-04-27 Amgen Inc Mammalian cell culture
AR089231A1 (es) * 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
US20150004686A1 (en) 2012-02-02 2015-01-01 Corning Incorporated Automatic continuous perfusion cell culture microplate consumables
WO2013151616A1 (en) 2012-04-01 2013-10-10 Emd Millipore Corporation Cell culture and gradient migration assay methods and devices
US20140154726A1 (en) * 2012-10-23 2014-06-05 Genzyme Corporation Perfusion Culturing Methods and Uses Thereof
EP3460049A1 (en) 2013-02-22 2019-03-27 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
SG11201506343QA (en) 2013-02-22 2015-09-29 Genzyme Corp Microcarrier perfusion culturing methods and uses thereof
IL274646B (en) 2013-03-08 2022-09-01 Genzyme Corp Integrated continuous production of medicinal substances from medical protein
CN112410279A (zh) 2013-03-15 2021-02-26 建新公司 高密度细胞存储方法
DK3047013T3 (da) 2013-09-16 2021-11-15 Genzyme Corp Fremgangsmåder og systemer til forarbejdning af en cellekultur
WO2015095809A1 (en) 2013-12-20 2015-06-25 Biogen Idec Ma Inc. Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
HUE042277T2 (hu) 2014-06-04 2019-06-28 Amgen Inc Eljárások fehérjék begyûjtésére emlõssejttenyészetekbõl
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
CN104450597B (zh) 2014-12-10 2020-07-28 青岛农业大学 一种石油降解菌固体菌剂的制备方法及由其制备的固体菌剂修复石油污染的土壤的方法
BR112017013423B1 (pt) 2014-12-22 2023-04-11 Genzyme Corporation Métodos para cultivo de célula de mamífero

Also Published As

Publication number Publication date
KR102584375B1 (ko) 2023-09-27
AU2021245116A1 (en) 2021-10-28
BR112016028891A2 (pt) 2017-08-22
AU2021245116B2 (en) 2023-07-27
IL249452B (en) 2021-04-29
DK3152299T3 (da) 2020-02-24
JP7089000B2 (ja) 2022-06-21
TWI776235B (zh) 2022-09-01
RU2016151316A (ru) 2018-07-10
CN111575225B (zh) 2023-09-08
BR112016028891B1 (pt) 2023-04-11
EP3628730A1 (en) 2020-04-01
RU2016151316A3 (el) 2018-11-15
US20150353896A1 (en) 2015-12-10
CN106574249B (zh) 2020-05-08
IL290096A (en) 2022-03-01
US10570367B2 (en) 2020-02-25
SG11201610216UA (en) 2017-01-27
MX2016016301A (es) 2017-04-06
WO2015191462A1 (en) 2015-12-17
IL290096B1 (en) 2023-12-01
MX2020004073A (es) 2020-07-29
CN111575225A (zh) 2020-08-25
KR20170015472A (ko) 2017-02-08
KR20220098051A (ko) 2022-07-08
ES2773630T3 (es) 2020-07-13
JP6784600B2 (ja) 2020-11-11
AU2015274897B2 (en) 2021-11-04
KR102416402B1 (ko) 2022-07-04
IL281626A (en) 2021-05-31
IL249452A0 (en) 2017-02-28
TWI707949B (zh) 2020-10-21
TW202246486A (zh) 2022-12-01
RU2019119708A (ru) 2019-07-03
IL281626B (en) 2022-03-01
HUE047683T2 (hu) 2020-05-28
EP3858983A1 (en) 2021-08-04
JP2022120031A (ja) 2022-08-17
CA2951551A1 (en) 2015-12-17
EP3152299A1 (en) 2017-04-12
AU2015274897A1 (en) 2017-01-12
AU2023203734A1 (en) 2023-07-06
IL290096B2 (en) 2024-04-01
JP2021019621A (ja) 2021-02-18
TW201610148A (zh) 2016-03-16
CN106574249A (zh) 2017-04-19
RU2694327C2 (ru) 2019-07-11
CA2951551C (en) 2023-02-28
EP3152299B1 (en) 2019-11-20
TW202102658A (zh) 2021-01-16
JP2017521057A (ja) 2017-08-03
JP7360504B2 (ja) 2023-10-12
US20200377850A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
CY1122803T1 (el) Διαδικασιες γραμμης παραγωγης σπορων και χρησεις αυτων
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
DK3107938T3 (da) Modificerede, antigenbindende polypeptidkonstrukter og anvendelser heraf
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
MY176855A (en) Anti-jagged1 antibodies and methods of use
DK3474802T3 (da) Medicinsk forbinding
DK3143138T3 (da) Betinget aktive biologiske proteiner
DK3237432T3 (da) Proteinfremstilling
DK3368655T3 (da) Forbedret proteinekspression og fremgangsmåder dertil
DK3145946T3 (da) Bakteriebaseret proteintilførsel
CY1124727T1 (el) Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων
DK3099791T3 (da) Protein
DK3130669T3 (da) Ny bakteriophag og sammensætning omfattende denne
BR112017011543A2 (pt) peptídeos cíclicos derivados de cd44v6 para o tratamento de cânceres e doenças relacionadas à angiogênese
DK3380496T3 (da) Forbedret proteinproduktion og fremgangsmåder hertil
BR112017008097A2 (pt) método para tratar condições oculares
MX2016016233A (es) Anticuerpos anti-lgr5 y sus usos.
DK3099793T3 (da) Protein
DK3194583T3 (da) Ikke-fucosyleret protein og fremgangsmåder dermed
DK3590523T3 (da) Vækstfremmende peptider og anvendelser deraf
DK3178838T3 (da) Koc1-afledt peptid og vaccine, der indbefatter dette
DK3795130T3 (da) Terapiapparat.
DK3302527T3 (da) Manipuleret CCL20-låst-dimerpolypeptid
DK3178837T3 (da) Urlc10-afledt peptid og vaccine, der indeholder dette